Quince Therapeutics Inc’s recently made public that its CEO AND CHIEF MEDICAL OFFICER Thye Dirk acquired Company’s shares for reported $53900.0 on Aug 30 ’24. In the deal valued at $0.70 per share,77,000 shares were bought. As a result of this transaction, Thye Dirk now holds 843,941 shares worth roughly $0.92 million.
Then, Thye Dirk bought 77,500 shares, generating $53,475 in total proceeds. Upon buying the shares at $0.69, the CEO AND CHIEF MEDICAL OFFICER now owns 766,941 shares.
Before that, Ryan Charles S. bought 48,387 shares. Quince Therapeutics Inc shares valued at $31,452 were divested by the PRESIDENT at a price of $0.65 per share. As a result of the transaction, Ryan Charles S. now holds 122,461 shares, worth roughly $0.13 million.
Oppenheimer initiated its Quince Therapeutics Inc [QNCX] rating to an Outperform in a research note published on March 24, 2025; the price target was $10.
Price Performance Review of QNCX
On Monday, Quince Therapeutics Inc [NASDAQ:QNCX] saw its stock jump 2.83% to $1.09. Over the last five days, the stock has lost -3.80%. Quince Therapeutics Inc shares have fallen nearly -41.71% since the year began. Nevertheless, the stocks have risen 9.72% over the past one year. While a 52-week high of $2.45 was reached on 01/06/25, a 52-week low of $0.51 was recorded on 04/11/25. SMA at 50 days reached $1.2636, while 200 days put it at $1.2561.
Levels Of Support And Resistance For QNCX Stock
The 24-hour chart illustrates a support level at 1.0467, which if violated will result in even more drops to 1.0034. On the upside, there is a resistance level at 1.1466. A further resistance level may holdings at 1.2032. The Relative Strength Index (RSI) on the 14-day chart is 43.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0025, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.56%. Stochastics %K at 41.95% indicates the stock is a holding.
How much short interest is there in Quince Therapeutics Inc?
A steep rise in short interest was recorded in Quince Therapeutics Inc stocks on 2025-04-15, dropping by -0.27 million shares to a total of 1.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 1.69 million shares. There was a decline of -19.35%, which implies that there is a negative sentiment for the stock.
